comScore
★ What is Gossip Cop? Find out!

Eminem Opens Up About Drug Addiction: “My Bottom Was Gonna Be Death”

Truth rating: 10

By Daniel Gates

(Getty Images)

Eminem opens up about his addiction to prescription pills in the new documentary How To Make Money Selling Drugs.

“When I took my first Vicodin, it was like this feeling of ‘Ahh.’ Like everything was not only mellow, but [I] didn’t feel any pain,” recalls the rapper.

But things got out of control.

He explains, “I don’t know at what point exactly it started to be a problem. I just remember liking it more and more. People tried to tell me that I had a problem.”

“I would say ‘Get that f**king person outta here,’” says Eminem. “I can’t believe they said that sh*t to me. I’m not out there shooting heroin. I’m not f**king out there putting coke up my nose. I’m not smoking crack.”

The music icon began to use even more drugs.

“Xanax, Valium… it’s same thing,” he says now. “F**k it, take it.”

Eminem was ultimately hospitalized, and found himself near death.

He reflects, “Had I got to the hospital about two hours later, I would have died. My organs were shutting down. My liver, kidneys, everything. They were gonna have to put me on dialysis. They didn’t think I was gonna make it. My bottom was gonna be death.”

After a relapse, Eminem eventually kicked the habit through detox, restarting his life.

He says, “I had to regain motor skills, I had to regain talking skills. It’s been a learning process, I’m growing. I couldn’t believe that anybody could be naturally happy without being on something. So I would say to anybody, ‘It does get better.’”

How To Make Money Selling Drugs, from director Matthew Cooke, a candid look at drug dealing in America today, also features 50 Cent, Susan Sarandon, Woody Harrelson, Russell Simmons, and “The Wire” creator David Simon.

Follow @GossipCop on Twitter!

Like us on Facebook!

 


  1. Gossip Cop
  2. Mediaite
  3. Styleite
  4. SportsGrid
  5. The Mary Sue
  6. The Maude
  7. The Braiser
CloseSubscribe to Gossip Cop's newsletter: